Berkshire, United Kingdom

Rino Rappuoli

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Seqirus UK Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rino Rappuoli. Retrieved from https://idiyas.com/inventor/rino-rappuoli-rlbbunar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rino Rappuoli: Innovator in Vaccination for Immunocompromised Individuals

Introduction

Rino Rappuoli is a prominent inventor based in Berkshire, GB. He has made significant contributions to the field of immunology, particularly in the development of vaccination methods for immunocompromised individuals. His work is crucial in enhancing immune responses in patients who may not respond effectively to standard vaccinations.

Latest Patents

Rappuoli holds a patent titled "Vaccination of immunocompromised subjects." This patent discloses methods for enhancing immune responses to a vaccine in immunocompromised individuals, including those receiving statin therapy. The related products provided in this patent aim to improve vaccination outcomes for vulnerable populations.

Career Highlights

Rino Rappuoli is currently associated with Seqirus UK Limited, where he continues to innovate in the field of vaccine development. His expertise and dedication to improving public health through vaccination have established him as a key figure in the industry.

Collaborations

Throughout his career, Rappuoli has collaborated with notable colleagues, including Giuseppe Del Giudice and Steven Black. These partnerships have furthered research and development in immunology and vaccine technology.

Conclusion

Rino Rappuoli's contributions to vaccination for immunocompromised individuals highlight his commitment to advancing medical science. His innovative approaches and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…